FDA’s new guidance on cannabis drug development won’t define path for CBD products, legal experts say

Federal food and drug officials dropped draft guidance for clinical research related to cannabis and cannabis-derived products.

FDA’s new guidance on cannabis drug development won’t define path for CBD products, legal experts say is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs